ARTICLE | Company News
3TC approved in Japan
September 22, 2000 7:00 AM UTC
BioChem Pharma (BCHE; TSE:BCH) and marketing partner Glaxo Wellcome (GLX; LSE:GLXO) received approval in Japan for BCHE's Zefix lamivudine 3TC nucleoside analog to treat chronic hepatitis B virus (HBV...